|
| Press Releases |
|
 |
|
| Thursday, December 1, 2016 |
|
|
Luye Pharma Announces the Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business |
| Luye Pharma Group Ltd. (2186.HK) is pleased to announce the completion of its acquisition of the transdermal drug delivery systems (TDS) business from Swiss company, Acino. The acquired business is a global leader in niche transdermal markets and will greatly enhance Luye's developmental efforts in R&D, more info >> |
|
| Tuesday, July 26, 2016 |
|
|
綠葉製藥國際化邁出里程碑意義的一步 宣布簽約收購瑞士Acino公司之透皮釋藥業務 |
| 2016年7月25日，綠葉製藥集團有限公司(2186.HK)欣然宣布，與瑞士Acino公司簽約，以2.45億歐元購買旗下透皮釋藥業務，即Acino AG和Acino Supply AG（統稱“標的公司”）全部發行之股本。 more info >> |
|
|
绿叶制药国际化迈出里程碑意义的一步 宣布签约收购瑞士Acino公司之透皮释药业务 |
| 2016年7月25日，绿叶制药集团有限公司(2186.HK)欣然宣布，与瑞士Acino公司签约，以2.45亿欧元购买旗下透皮释药业务，即Acino AG和Acino Supply AG（统称“标的公司”）全部发行之股本。 more info >> |
|
|
Luye Pharma Takes a Milestone Step Forward; Proposed Acquisition of Acino's TDS Business |
Luye Pharma Group Ltd. (2186.HK) (the "Company", and together with its subsidiaries, "Luye Pharma" or the "Group") announces its agreement to acquire the TDS business from Acino, through the purchase of the entire issued share capital of Acino AG and Acino Supply AG (the "Target Group") for EUR245,000,000 (the "Acquisition").
more info >> |
|
| Friday, May 6, 2016 |
|
|
Luye Medical welcomes Australia's Healthe Care to its Group |
| Healthe Care, Australia's third largest private healthcare group, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund completed on April 18. more info >> |
|
| Sunday, April 24, 2016 |
|
|
Singapore-based Luye Medical Group Completes Acquisition of Healthe Care, Australia's Third Largest Private Healthcare Group |
| On April 18, 2016, Australia's third largest private healthcare group, Healthe Care, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund was completed. more info >> |
|
| Friday, October 9, 2015 |
|
|
China's First Innovative Drug Led by Luye Pharma Approved NDA in the U.S. |
| The leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd. (the "Company", together with its subsidiaries, "Luye", stock code: 2186.HK), announced that the United States Food and Drug Administration (the "FDA") has confirmed that no additional clinical trials are needed for the New Drug Application ("NDA") submission for Risperidone Extended-release Microspheres for Injection ("LY03004") in the U.S. more info >> |
|
|
由綠葉製藥研發的我國首個創新藥獲批在美提交新藥申請 |
| 以研發為驅動，以國際化為目標的中國領先創新製藥企業--綠葉製藥集團(簡稱「公司」，連同其附屬公司，統稱「綠葉」，股份代號：2186.HK)，近日宣佈，美國食品藥品監督管理局（FDA）確認公司研發的利培酮微球注射劑（LY03004）不需再進行任何臨床試驗，可在美提交新藥申請（NDA）。 more info >> |
|
| Tuesday, June 2, 2015 |
|
|
綠葉製藥宣佈終止收購北京嘉林藥業股權之協議 |
以研發為驅動，以國際化為目標的中國領先創新製藥企業--綠葉製藥集團(股份代號：2186.HK)宣佈，終止收購北京嘉林藥業股份有限公司之股權協議。公司股票在短暫停牌後於今日恢復交易。
more info >> |
|
| Thursday, May 14, 2015 |
|
|
綠葉製藥被納入MSCI中國指數 |
| 以研發為驅動，以國際化為目標的中國領先創新製藥企業--绿叶制药集团(股份代號：2186.HK)宣佈绿叶獲納入摩根士丹利資本國際(「MSCI」)環球標準指數系列中的中國指數成分股，將於今年5月29日收市後生效 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.
Feb 7, 2026 05:45 HKT/SGT
|
|
|
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 6, 2026 17:45 HKT/SGT
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 17:01 HKT/SGT
|
|
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 6, 2026 16:56 HKT/SGT
|
|
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 6, 2026 16:50 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 16:34 HKT/SGT
|
|
|
トヨタ、役員人事を発表
Feb 6, 2026 16:00: JST
|
|
|
牧原股份港股上市：全球生豬养殖龍頭 價值成長兼具
Feb 6, 2026 15:08 HKT/SGT
|
|
|
牧原股份港股上市：全球生猪养殖龙头 价值成长兼具
Feb 6, 2026 15:01 HKT/SGT
|
|
|
優異供應鏈賦能與國際化佈局雙輪驅動 綠茶開啟高質量成長新篇章
Feb 6, 2026 14:47 HKT/SGT
|
|
|
优异供应链赋能与国际化布局双轮驱动 绿茶开启高质量成长新篇章
Feb 6, 2026 14:33 HKT/SGT
|
|
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 14:17 HKT/SGT
|
|
|
雲頂新耀維適平(R)獲中國國家藥品監督管理局批准上市 為中重度潰瘍性結腸炎治療提供新選擇
Feb 6, 2026 14:11 HKT/SGT
|
|
|
云顶新耀维适平(R)获中国国家药品监督管理局批准上市 为中重度溃疡性结肠炎治疗提供新选择
Feb 6, 2026 14:03 HKT/SGT
|
|
|
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025
Feb 6, 2026 13:13 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
